S. Kilickap And C. Arslan, "Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis: how much is it true?," ANNALS OF ONCOLOGY , vol.21, no.4, pp.902-903, 2010
Kilickap, S. And Arslan, C. 2010. Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis: how much is it true?. ANNALS OF ONCOLOGY , vol.21, no.4 , 902-903.
Kilickap, S., & Arslan, C., (2010). Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis: how much is it true?. ANNALS OF ONCOLOGY , vol.21, no.4, 902-903.
Kilickap, S., And C. Arslan. "Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis: how much is it true?," ANNALS OF ONCOLOGY , vol.21, no.4, 902-903, 2010
Kilickap, S. And Arslan, C.. "Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis: how much is it true?." ANNALS OF ONCOLOGY , vol.21, no.4, pp.902-903, 2010
Kilickap, S. And Arslan, C. (2010) . "Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis: how much is it true?." ANNALS OF ONCOLOGY , vol.21, no.4, pp.902-903.
@article{article, author={S. Kilickap And author={C. Arslan}, title={Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis: how much is it true?}, journal={ANNALS OF ONCOLOGY}, year=2010, pages={902-903} }